Investigation of apomorphine during sleep in Parkinson’s: Improvement in UPDRS Scores
Sleep is responsible for several functions required for homeostasis. REM sleep could be a rearrangement period where limits of certain functions can be moved to a new state of balance. This study proposes that dopaminergic deficit may be responsible for the circadian dysregulation that occur with ne...
Main Author: | Miguel A. Pieroni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-12-01
|
Series: | Neurology International |
Subjects: | |
Online Access: | https://www.pagepress.org/journals/index.php/ni/article/view/8207 |
Similar Items
-
Apomorphine in the Treatment of Parkinson’s Disease
by: Serhat Özkan
Published: (2021-12-01) -
Continuous subcutaneous apomorphine monotherapy in Parkinson’s disease
by: Ewa Papuć, et al.
Published: (2019-03-01) -
Apomorphine in the treatment of Parkinson's disease: a review
by: Renata Ramina Pessoa, et al. -
Subcutaneous apomorphine in advanced Parkinson’s disease and its use in Indian population
by: Vinod Metta, et al.
Published: (2020-01-01) -
Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
by: Angelo Antonini
Published: (2009-05-01)